ResearcherHarvard UniversityActive in the last 2 years

Naiara Santana-Codina

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8250-4530; OpenAlex author ID A5020799667. Sources: OpenAlex.

Their work

Papers: 3 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 11

Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 3

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Andrew J. Aguirre · 2 shared papers, 2022–2025 · strength 0.32
- Paper De novo pyrimidine biosynthesis inhibition synergizes with BCL-XL targeting in pancreatic cancer. DOI 10.1038/s41467-025-61242-x ↗
- Paper NCOA4-Mediated Ferritinophagy Is a Pancreatic Cancer Dependency via Maintenance of Iron Bioavailability for Iron-Sulfur… DOI 10.1158/2159-8290.cd-22-0043 ↗
Joseph Douglas Mancias · 2 shared papers, 2022–2025 · strength 0.32
- Paper De novo pyrimidine biosynthesis inhibition synergizes with BCL-XL targeting in pancreatic cancer. DOI 10.1038/s41467-025-61242-x ↗
- Paper NCOA4-Mediated Ferritinophagy Is a Pancreatic Cancer Dependency via Maintenance of Iron Bioavailability for Iron-Sulfur… DOI 10.1158/2159-8290.cd-22-0043 ↗
Huan Zhang · 1 shared paper, 2025 · strength 0.20
- Paper De novo pyrimidine biosynthesis inhibition synergizes with BCL-XL targeting in pancreatic cancer. DOI 10.1038/s41467-025-61242-x ↗
Stephanie K. Dougan · 1 shared paper, 2025 · strength 0.20
- Paper De novo pyrimidine biosynthesis inhibition synergizes with BCL-XL targeting in pancreatic cancer. DOI 10.1038/s41467-025-61242-x ↗
Annan Yang · 2 shared papers, 2018–2022 · strength 0.19
- Paper NCOA4-Mediated Ferritinophagy Is a Pancreatic Cancer Dependency via Maintenance of Iron Bioavailability for Iron-Sulfur… DOI 10.1158/2159-8290.cd-22-0043 ↗
- Paper Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis. DOI 10.1038/s41467-018-07472-8 ↗
Douglas E. Biancur · 1 shared paper, 2022 · strength 0.12
- Paper NCOA4-Mediated Ferritinophagy Is a Pancreatic Cancer Dependency via Maintenance of Iron Bioavailability for Iron-Sulfur… DOI 10.1158/2159-8290.cd-22-0043 ↗
Jonathan Andrew Nowak · 1 shared paper, 2022 · strength 0.12
- Paper NCOA4-Mediated Ferritinophagy Is a Pancreatic Cancer Dependency via Maintenance of Iron Bioavailability for Iron-Sulfur… DOI 10.1158/2159-8290.cd-22-0043 ↗
Anjali A. Roeth · 1 shared paper, 2018 · strength 0.08
- Paper Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis. DOI 10.1038/s41467-018-07472-8 ↗
Haoqiang Ying · 1 shared paper, 2018 · strength 0.08
- Paper Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis. DOI 10.1038/s41467-018-07472-8 ↗
Alec C. Kimmelman · 1 shared paper, 2018 · strength 0.08
- Paper Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis. DOI 10.1038/s41467-018-07472-8 ↗
Costas Andreas Lyssiotis · 1 shared paper, 2018 · strength 0.08
- Paper Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis. DOI 10.1038/s41467-018-07472-8 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.